Музаффар Илхомжон Асомов

4 та иш

Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan

1. #1796 The impact of metabolic syndrome components on renal function in patients with heart failure

   Музаффар Илхомжон Асомов, Gulchehra Atakhodjayeva, Olimkhon Sharapov +1

   МақолаDiabetes Treatment and ManagementNephrology Dialysis Transplantation20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009271

2. #1825 Monitoring of atrial indicators in patients with chronic kidney disease and atrial fibrillation after radio-frequency ablation

   Ranokhon Igamberdieva, Sherzod Abdullaev, Музаффар Илхомжон Асомов

   МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009272

3. #2598 Impact of empagliflozin on metabolic profile, anthropometric indices, and renal function in chronic kidney disease patients with non-alcoholic fatty liver disease

   Rakhimjon Tursunbayev, Sherzod Abdullaev, Музаффар Илхомжон Асомов +1

   МақолаLiver Disease Diagnosis and TreatmentNephrology Dialysis Transplantation20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009281

4. #1800 Cardiorenal relationships: correlation analysis of the effect of metabolic syndrome components on renal and cardiac function in heart failure patients with mid-range ejection fraction

   Музаффар Илхомжон Асомов, Gulchehra Atakhodjayeva, Olimkhon Sharapov +3

   МақолаDiabetes Management and ResearchNephrology Dialysis Transplantation20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009283